Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
Mario Negri Institute for Pharmacological Research · Azienda Ospedaliero Universitaria Ospedali Riuniti · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
644
total citations
- FWCI
- 22.13
- Percentile
- 100%
- References
- 39
Citations per year
Authors
18- PRPiero Ruggenenti
Mario Negri Institute for Pharmacological Research, Azienda Ospedaliero Universitaria Ospedali Riuniti
- APAnnalisa Perna
Mario Negri Institute for Pharmacological Research
- GLGiacomina Loriga
Mario Negri Institute for Pharmacological Research
- MGMaría Ganeva
Medical University Plovdiv, Mario Negri Institute for Pharmacological Research
- BEBogdan Ene‐Iordache
Mario Negri Institute for Pharmacological Research
Topics & keywords
Topics
Keywords
- Medicine
- Felodipine
- Ramipril
- Blood pressure
- Amlodipine
- Internal medicine
- Kidney disease
- ACE inhibitor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.